Another positive DEP announcement.
DEPs reduction in toxicity is consistently positive along with further efficacy signs, even if only phase I it is consistent with other trials.
a positive from the announcement is that they state recruitment is underway. I thought they would not be able to enrol new patients?
SPL requires a lot of patience, but I’m confident DEP will be huge, commercially and for patients. When though...
Ann: DEP irinotecan phase 2 commences after positive phase 1, page-6
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |